Clinical Trial

Rockwood Frailty Index and Survival in Hospital-at-Home Patients

Study acronym: DOMMOR
Completed
View on ClinicalTrials.gov →
Summary
Frailty is a key determinant of prognosis in older adults with complex chronic conditions and in palliative care settings. The Rockwood Frailty Index (RFI), based on the accumulation of health deficits, has demonstrated prognostic value across multiple clinical contexts. This study evaluates the association between the RFI and overall survival in complex chronic and palliative patients (oncologic and non-oncologic) treated in a Hospital-at-Home (HaH) unit.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-08.
Trial Details
NCT Number NCT07529470
Lead Sponsor Instituto de Investigacion Sanitaria La Fe
Conditions Home Care Services, Hospital-Based, Frailty, Mortality, Palliative Care
Enrollment 2,610 participants
Start Date 2021-01-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-21